The advantages of insulin pump therapy and real time glucose monitoring systems as the tools for reducing the frequency of hypoglycemic episodes in the children and adolescents with type 1 diabetes mellitus

The primary objective of the present study was to analyse the advantages of insulin pump therapy and real time glucose monitoring systems as the tools for reducing the frequency of hypoglycemic episodes. The study included 190 children and adolescents at the age varying from 1 to 18 years suffering from type 1 diabetes mellitus. All the patients were hospitalized at the Endocrinological Research Centre for the treatment the disease using different modalities of insulin therapy, such as multiple injections of insulin (MII) and its continuous subcutaneous infusion (CSII). The blood glucose level was monitored during 72 hours making use of the continuous blind and real time monitoring protocols (blind-CGM and RT-CGM respectively). All the patients were divided into 4 groups depending on the therapeutic modality and the mode of blood glucose monitoring. Group 1 was comprised of the patients given multiple insulin injections in combination with blind glucose monitoring ("blind-CGM + MII"), group 2 included the patients undergoing blind glucose monitoring in conjunction with continuous insulin infusion ("blind-CGM + CSII"), group 3 contained the patients treated by multiple insulin injections followed by real-time blood glucose monitoring ("RT-CGM + MII"), and group 4 was composed of the patients undergoing continuous subcutaneous infusion of insulin combined with real-time blood glucose monitoring ("RT-CGM + CSII"). In all the cases, the blood glucose levels were measured and the occurrence of hypoglycemia during the period of monitoring time was evaluated. It was shown that the highest frequency of hypoglycemia during 72 hours was recorded in the "blind-CGM" group and the lowest one in the RT-CGM groups. Despite adequate self-control, almost half of the patients in the "blind-CGM + MII" group reported at least one hypoglycemic episode either at the daytime or at night ; the duration of such episode was more than 1 hour on the average. In the "blind-CGM" group, CSII resulted in the decrease of the number of hypoglycemic episodes both at night and daytime (p<0.05). In the "RT-CGM + CSII" group, continuous insulin infusion reduced the mean duration of nocturnal hypoglycemic episodes (p<0.05) whereas this parameter was not significantly different between the other groups. It is concluded that hypoglycemia especially nocturnal one is rather a common problem facing children and adolescents suffering from type 1 diabetes mellitus. The use of insulin pump therapy and real time glucose monitoring systems (RT-CGM) makes it possible to substantially decrease the frequency and duration of hypoglycemic episodes in this population group.

diabetes mellitus, hypoglycemia, long-term blood glucose monitoring, insulin pump therapy, children, adolescents

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.

2. Shalitin S, Phillip M. Hypoglycemia in type 1 diabetes: a still unresolved problem in the era of insulin analogs and pump therapy. Diabet Care 2008; 31(Suppl. 2): S121-S124.

3. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, Band MM, Reekie G, Leese GP. DARTS/MEMO Collaboration. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005; 22: 749-755.

4. U.K. Hypoglycaemia Study Group: Risk of hypoglycaemia in type 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50: 1140-1147.

5. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-termcomplications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994; 125: 177-188.

6. Bulsara MK, Holman CDJ, Davis EA, Jones TW. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1 diabetes. Diabet Care 2004; 27: 2293-2298.

7. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabet Care 2003; 26: 1902-1912.

8. Ahmet A, Dagenais S, Barrowman NJ, Collins CJ, Lawson ML. Prevalence of Nocturnal Hypoglycemia in Pediatric Type 1 Diabetes: A Pilot Study Using Continuous Glucose Monitoring. J Pediatr 2011; 159(2): 297-302.e1. doi: 10.1016/j.jpeds.2011.01.064.

9. Amin R, Ross K, Acerini CL, Edge JA, Warner J, Dunger DB. Hypoglycemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabet Care 2003; 26: 3: 662-667.

10. Cryer PE. Diverse causes of hypoglycemiaassociated autonomic failure in diabetes. N Engl J Med 2004; 350: 2272-2279.

11. Seaquist ER, Anderson J, Childs B, Cryer P, Dagogo-Jack S, Fish L, Heller SR, Rodriguez H, Rosenzweig J, Vigersky R. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabet Care 2013; 36(5):1384-1395. doi: 10.2337/dc12-2480.

12. Sovik O, Thordarson H. Dead-in-bed syndrome in young diabetic patients. Diabet Care 1999; 22(Suppl. 2): B40-B42.

13. Лаптев Д.Н., Рябыкина Г.В., Сеид-Гуссейнов А.А. Изменение длительности интервала QT у детей и подростков, больных сахарным диабетом 1-го типа. // Кардиология 2007; 47(12): 35-39.

14. Лаптев Д.Н., Шмушкович И.А. Аритмогенный эффект гипогликемии. // Сахарный диабет. - 2012. - №1 - С. 25-30. doi: 10.14341/2072-0351-5975.

15. Haugstvedt A, Wentzel-Larsen T, Graue M, Søvik O, Rokne B. Fear of hypoglycaemia in mothers and fathers of children with type 1 diabetes is associated with poor glycaemic control and parental emotional distress: a population-based study. Diabet Med 2010; 27(1): 72-78.

16. Northam EA, Anderson PJ, Jacobs R, Hughes M, Warne GL, Werther GA. Neuropsychological profiles of children with type 1 diabetes 6 years after disease onset. Diabet Care 2001; 24(9): 1541-1546.

17. Hannonen R, Tupola S, Ahonen T, Riikonen R. Neurocognitive functioning in children with type-1 diabetes with and without episodes of severe hypoglycaemia. Dev Med Child Neurol 2003; 45(4): 262-268.

18. Perantie DC, Lim A, Wu J, Weaver P, Warren SL, Sadler M, White NH, Hershey T. Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabet 2008; 9(2): 87-95. doi: 10.1111/j.1399-5448.2007.00274.x.

19. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabet Care 2009; 32: 1378-1383.

20. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabet Care 2010; 33(Suppl. 1): S11-S61.

21. Kordonouri O, Pankowska E, Rami B et al. Sensoraugmented pump therapy from diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Diabetologia 2010; 53: 2487-2495.

22. Емельянов А.О., Кураева Т.Л., Лаптев Д.Н., Петеркова В.А. Проспективное наблюдение эффективности и безопасности помповой инсулинотерапии у детей и подростков. // Сахарный диабет. - 2010. - №3 - С. 143-146. doi: 10.14341/2072-0351-5503.

23. Лаптев Д.Н. Помповая инсулинотерапия с функцией автоматического прекращения подачи инсулина в ответ на гипогликемию. // Проблемы эндокринологии. - 2012. - Т. 58. - №3 - С. 70-74. doi: 10.14341/probl201258370-74.

24. Дедов И.И., Петеркова В.А., Кураева Т.Л., Емельянов А.О., Андрианова Е.А., Лаптев Д.Н. Помповая инсулинотерапия сахарного диабета у детей и подростков. Российский консенсус детских эндокринологов. // Проблемы эндокринологии. - 2012. - Т. 58. - №2 - С. 3-18.

25. Phillip M, Battelino T, Rodriguez H, Danne T, Kaufman F. Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabet Care 2007;30(6):1653-1662. doi: 10.2337/dc07-9922.

26. Danne T, Battelino T, Jarosz-Chobot P, Kordonouri O, Pánkowska E, Ludvigsson J, et al. Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia 2008;51(9):1594-1601.

27. Волеводз Н.Н., Лаптев Д.Н., Шестакова М.В. Современные подходы к базисно-болюсной инсулинотерапии с использованием аналогов инсулина гларгин и глулизин в разных возрастных группах. // Сахарный диабет. - 2013. - №1 - С. 83-90. doi: 10.14341/2072-0351-3602.

28. Scheiner G, Boyer BA. Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy. Diabet Res Clin Pract 2005; 69: 14-21.

29. Wilkinson J, Chase HP, McFann K. Factors affecting improved glycemic control in youth using insulin pumps. Diabetes 2009; 58(Suppl. 1): A459.

30. Phillip M, Danne T, Shalitin S, Buckingham B, Laffel L, Tamborlane W, Battelino T. Use of continuous glucose monitoring in children and adolescents. Pediatr Diabet 2012;13(3):215-228. doi: 10.1111/j.1399-5448.2011.00849.x.